Long-term glucagon-like peptide-1 (GLP-1) therapies combined with intensive behavioral therapy are recommended for adults with obesity.

The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

Medline has put forward terms for an absolutely massive IPO, which could see the medical device manufacturing and ...

As people with type 1 diabetes live longer than ever before, both clinicians and patients are recognizing the need to prepare ...

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

Socioeconomic vulnerability and multiple medical comorbidities are risk factors for late-onset depression among long-term ...

(a), taxpayers may deduct expenses paid during the tax year for medical care, provided these expenses are not compensated by ...

Pass-fail assessment is the norm in preclerkship courses. These tips can help medical students optimize their learning and ...

That and other non-fruit related high jinks are afoot as the stars of The Pitt mingle on a backstage set for Entertainment ...

The study, which clocked wait times for common types of surgery and medically necessary elective specialist treatments across ...

Donation complements Oregon’s landmark medical-debt legislation and the state’s transition to a fully state-based insurance ...

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...